Eastern Hepatobiliary Surgery Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Established: 1956-01-01

Employees: -

Market Cap: -

Website: http://www.ehbh.cn/

Clinical Trials

Prospective Randomized Study of Glucocorticoids in the Impact of the Liver Function and the Prognosis After Hepatectomy of HCC

Suspended

Conditions: Some Studies Shows That the Steroid Can Reduce the Injury of the I/R of the Liver

Interventions: Drug: Hydrocortisone sodium succinate

First Posted Date: 2012-05-31

Last Posted Date: 2012-05-31

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 60

Registration Number: NCT01608945

A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Procedure: Pringle's Maneuver
Procedure: Portal vein occlusion
Procedure: Hemihepatic vascular Clamping

First Posted Date: 2009-02-26

Last Posted Date: 2016-04-01

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 320

Registration Number: NCT00851968

Locations: 🇨🇳
Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China

Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients

Phase 2

Completed

Conditions: Hepatocellular Carcinoma
Portal Vein Tumor Thrombus

Interventions: Drug: chemotherapy with endostar
Drug: treatment with CBP and 5-FU
Drug: treatment with endostar, CBP and 5-FU

First Posted Date: 2009-02-23

Last Posted Date: 2016-04-01

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 120

Registration Number: NCT00849264

Locations: 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Procedure: TACE
Procedure: PVE

First Posted Date: 2009-02-03

Last Posted Date: 2016-04-01

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 20

Registration Number: NCT00834158

Locations: 🇨🇳
Eastern Hepatobiliary Surgery Hospital, Shanghai, China

Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma

Phase 4

Completed

Conditions: Unresectable Hepatocellular Carcinoma

Interventions: Drug: Licartin
Procedure: Transcatheter arterial chemoembolization

First Posted Date: 2009-01-27

Last Posted Date: 2016-04-01

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 400

Registration Number: NCT00829465

Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Procedure: Hemihepatic vascular Clamping
Procedure: Pringle's Maneuver
Procedure: Total hemihepatic vascular exclusion

First Posted Date: 2009-01-22

Last Posted Date: 2016-04-01

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 150

Registration Number: NCT00827047

Locations: 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Phase 2

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Drug: LMWH
Procedure: TACE

First Posted Date: 2009-01-22

Last Posted Date: 2016-04-01

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 100

Registration Number: NCT00827554

Locations: 🇨🇳
Eastern Hepatobiliary Surgery Hospital, ShangHai, Shanghai, China

Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion

Phase 1

Completed

Conditions: Hepatocellular Carcinoma

First Posted Date: 2009-01-22

Last Posted Date: 2016-04-01

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 352

Registration Number: NCT00826384

Locations: 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Other: operation;TACE plus PEI

First Posted Date: 2009-01-21

Last Posted Date: 2016-04-01

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 160

Registration Number: NCT00825474

Locations: 🇨🇳
Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China

Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Drug: TACE
Procedure: Laser ablation

First Posted Date: 2009-01-21

Last Posted Date: 2016-04-01

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 100

Registration Number: NCT00825669

Locations: 🇨🇳
Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy